alpha-aminopyridine has been researched along with pf 3758309 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Coarfa, C; Dasgupta, A; Kurenbekova, L; Landesman, Y; Patel, T; Rainusso, N; Rajapakse, K; Shuck, RL; Sierra, L; Tsang, SV; Unger, T; Yustein, JT | 1 |
Coarfa, C; Kim, HR; Kurenbekova, L; Landesman, Y; Nakahata, K; Patel, TD; Qasim, SL; Rajapakshe, K; Shuck, R; Sierra, L; Unger, TJ; Wulff, J; Yustein, JT | 1 |
2 other study(ies) available for alpha-aminopyridine and pf 3758309
Article | Year |
---|---|
Targeting PAK4 Inhibits Ras-Mediated Signaling and Multiple Oncogenic Pathways in High-Risk Rhabdomyosarcoma.
Topics: Acrylamides; Aminopyridines; Animals; Apoptosis; Biomarkers, Tumor; Cell Movement; Cell Proliferation; Child; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; p21-Activated Kinases; Pyrazoles; Pyrroles; ras Proteins; Rhabdomyosarcoma; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
p21-activated kinases as viable therapeutic targets for the treatment of high-risk Ewing sarcoma.
Topics: Acrylamides; Aminopyridines; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Interferon-alpha; Interferon-gamma; p21-Activated Kinases; Pyrazoles; Pyrroles; Sarcoma, Ewing; Signal Transduction; Xenograft Model Antitumor Assays | 2021 |